Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
15.34
-0.44 (-2.79%)
Feb 27, 2026, 4:00 PM EST - Market closed
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $560.36 million as of February 27, 2026. Its market cap has increased by 179.57% in one year.
Market Cap
560.36M
Enterprise Value
383.45M
1-Year Change
179.57%
Ranking
Category
Stock Price
$15.34
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $560.36M, an increase of 39.36%. That is a compound annual growth rate of 19.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 431.29M | 34.21% |
| Dec 31, 2025 | 321.36M | -14.75% |
| Dec 31, 2024 | 376.94M | -6.25% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 596.76M |
| Design Therapeutics | 594.70M |
| Neumora Therapeutics | 593.09M |
| CorMedix | 561.77M |
| Larimar Therapeutics | 560.68M |
| Fulcrum Therapeutics | 558.11M |
| Rocket Pharmaceuticals | 542.19M |
| Altimmune | 539.75M |